Skip to main content
. 2018 Oct 11;10(10):1478. doi: 10.3390/nu10101478

Table 1.

Characteristics of the participants at baseline 1.

N Fish Group (n = 81) Meat Group (n = 89)
Demographics
Age, years 169 5.2 (0.6) 5.2 (0.5)
Body weight, kg 157 20.0 (3.4) 20.3 (2.9)
Body height, cm 159 114.1 (6.2) 113.8 (6.0)
Boys, n (%) 79 37 (45.7) 42 (47.2)
Girls, n (%) 91 44 (54.3) 47 (52.8)
Family income in NOK, n (%)
<200,000–749,999 43 21 (26.3) 22 (24.7)
750,000–1,249,999 99 43 (53.8) 56 (62.9)
1,250,000–>2,000,000 27 16 (20.0) 11 (12.4)
Education parents, years 169 15.5 (1.6) 15.4 (1.6)
Sleep
TIB, hour/min 169 11.23 (0.37) 11.18 (0.29)
Sleep duration, hour/min 169 10.55 (0.40) 10.45 (0.39)
WASO, minute/second 169 4.3 (8.6) 5.6 (10.5)
SOL, minute/second 169 23.9 (15.9) 27.4 (19.2)
SDQ
Emotional problems 169 1.4 (1.4) 1.2 (1.3)
Conduct problems 169 1.3 (1.2) 1.4 (1.2)
Hyperactivity/inattention 169 2.3 (2.1) 2.4 (2.0)
Peer problems 169 0.8 (1.2) 0.9 (1.2)
Total problems 169 5.9 (4.0) 5.8 (3.8)
Biological parameters
25(OH)D3, nmol/L serum 158 61.9 (14.5) 60.9 (14.1)
Ferritin, µg/L serum 162 32.4 (19.9) 27.5 (15.6)
EPA, 20:5 n-3, % of fatty acids in RBC 160 0.91 (0.43) 0.90 (0.35)
DHA, 22:6 n-3, % of fatty acids in RBC 160 6.7 (1.1) 6.4 (1.1)
Omega-3 index 2 160 7.4 (1.4) 7.3 (1.4)
UIC, µg/L urine 163 151.3 (96.1) 157.2 (98.6)
Dietary intake from FFQ, meals/week
Fish as dinner 169 1.8 (0.9) 1.6 (0.9)
Red meat as dinner 169 2.6 (0.8) 2.4 (1.0)
Chicken as dinner 169 1.4 (0.9) 1.1 (0.9)
Fish as spread 169 1.5 (1.5) 1.2 (1.3)
n-3 LC-PUFA supplements, n (%) 74 29 (35.8) 37 (41.6)
No n-3 LC-PUFA supplements, n (%) 123 52 (64.2) 52 (58.4)

1 Values are means (SD) unless otherwise noted. 2 The content of EPA and DHA expressed as percentages of total fatty acids. There were no significant differences between the study groups (p > 0.05). Abbreviations: FFQ, food frequency questionnaire; DHA, docosahexaenoic acids; EPA, eicosapentaenoic acids; NOK, Norwegian kroner; n-3 LC-PUFA, long chain omega-3. fatty acids; RBC, red blood cells; SDQ, strengths and difficulties questionnaire; s-25(OH)D3, serum 25-hydroxyvitamin D3; SOL, sleep onset Laency, TIB, time in bed; WASO, wake after sleep onset; UIC, urinary iodine concentration.